Medchal Malkajgiri, India
Aspen Biopharma Labs Pvt., Ltd. recalls
1 recall recorded since 2018, most recently on 7 February 2025. 1 is listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)1
Terminated or completed0
Class I (FDA)0
Ongoing Class II Drugs
- Recall started
- 7 February 2025
- Reason
- CGMP Deviations
- Distribution
- Product was distributed to 3 distributors (1 Hong Kong and 2 accounts in Florida)
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-0263-2025, D-0262-2025, D-0261-2025, D-0260-2025, D-0264-2025, D-0265-2025
- Chlorambucil Container Description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping.
- Finasteride NDC# 82187-1003-1 Container Description: The product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping.
- Alprostadil Container Description: Amber color bottle
- Bimatoprost NDC# 82187-1001-1 Container description: The product packed in double self-seal cover and finally packed in Aluminum cover for shipping.
- Latanoprost NDC# 82187-1002-1 Container Description: Amber colour bottle
- Voriconazole Container Description: voriconazole The product packed in white poly bag containing black poly bag and tied each individual finally packed in HDPE container for shipping.
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.